Showing results (1671-1680 of 6,511) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Bispecific-Ab-based immunoassay of thyroid-stimulating hormoneK InouyeCancer Immunology, Immunotherapy : CII|January 22, 1998
Bispecific antibody treatment of murine B cell lymphomaJ De Jonge, C Heirman, M De Veerman, et al.Cancer Immunology, Immunotherapy : CII|March 31, 1998
Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancerK Hiramatsu, H Yanagawa, T Haku, et al.Cancer Immunology, Immunotherapy : CII|March 31, 1998
Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin AD P Shrayer, N Kouttab, V J Hearing, et al.Cancer Immunology, Immunotherapy : CII|March 31, 1998
Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse modelN K Egilmez, Y S Jong, Y Iwanuma, et al.Cancer Immunology, Immunotherapy : CII|March 31, 1998
Interleukin-2: hope in cases of cisplatin-resistant tumoursM R Bernsen, A W Van Der Velden, L A Everse, et al.Cancer Immunology, Immunotherapy : CII|March 31, 1998
Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patientsS R Chinni, C Gerçel-Taylor, G E Conner, et al.Cancer Immunology, Immunotherapy : CII|March 7, 1998
Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccinesV Kudryashov, H M Kim, G Ragupathi, et al.Cancer Immunology, Immunotherapy : CII|March 7, 1998
Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patientsS H Choi, E J Chung, D Y Whang, et al.Cancer Immunology, Immunotherapy : CII|March 7, 1998
Transforming growth factor beta, (TGFbeta) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon gamma and tumor necrosis factor alpha reduces the production of active TGFbetaN Nagy, F VánkyPageof 652